Dowling & Yahnke LLC Amgen Inc Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Amgen Inc stock. As of the latest transaction made, Dowling & Yahnke LLC holds 33,391 shares of AMGN stock, worth $10.5 Million. This represents 3.5% of its overall portfolio holdings.

Number of Shares

33,391

Previous 33,136 0.77%

Holding current value

$10.5 Million

Previous $8.06 Million 6.65%

% of portfolio

3.5%

Previous 0.38%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $57,237 - $64,553	255 Added 0.77%	33,391 $7.53 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $197,026 - $219,255	854 Added 2.65%	33,136 $8.06 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $64,903 - $71,800	-296 Reduced 0.91%	32,282 $7.81 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $382,446 - $437,674	-1,923 Reduced 5.57%	32,578 $7.33 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $53,916 - $63,169	-254 Reduced 0.73%	34,501 $7.34 Million
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $83,621 - $92,772	358 Added 1.04%	34,755 $8.47 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $28,848 - $33,618	-130 Reduced 0.38%	34,397 $8.56 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $153,846 - $183,203	711 Added 2.1%	34,527 $7.94 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $59,131 - $65,759	-252 Reduced 0.74%	33,816 $8.6 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $84,860 - $104,135	-429 Reduced 1.24%	34,068 $8.04 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $11,116 - $14,743	-61 Reduced 0.18%	34,497 $6.99 Million
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $40,112 - $51,558	212 Added 0.62%	34,558 $8.33 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $481,240 - $576,625	-2,764 Reduced 7.45%	34,346 $6.65 Million
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $6.19 Million - $7.25 Million	37,110 New	37,110 $6.84 Million
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $6.61 Million - $7.72 Million	-37,060 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $81,342 - $91,702	-439 Reduced 1.17%	37,060 $7.68 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $60,774 - $68,262	-366 Reduced 0.97%	37,499 $6.92 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $148,928 - $174,042	-879 Reduced 2.27%	37,865 $6.46 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $103,468 - $115,605	613 Added 1.61%	38,744 $6.74 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $6.38 Million - $7.28 Million	38,131	38,131 $7.11 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Amgen Inc Transaction History